Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Barrick Faces Activist Pressure After Elliott Takes Major...

November 20, 2025

Maiden Drill Program Commences at Oasis Uranium Project

July 28, 2025

Stonegate Capital Partners Initiates Coverage on Heliostar Metals...

September 27, 2025

Coelacanth Announces Q4 2024 Financial and Operating Results

April 24, 2025

Crypto Market Recap: Kraken Expands Services, EURC Momentum...

April 15, 2025

Group Eleven Announces C$5M Bought Deal Private Placement

July 22, 2025

Rare Earths Stocks: 9 Biggest Companies in 2025

April 8, 2025

Skyharbour Resources

June 14, 2025

Silver Price Update: Q2 2025 in Review

July 17, 2025

Asara raises $25m to accelerate exploration at Kada

July 28, 2025